The first set of monitoring data for the pilot has been collated and the pharmacist interventions made have been graded and a monetary value assigned for cost avoidance to the healthcare system from that intervention.
Of the interventions that have been graded, a cost avoidance of has been calculated of £50,785 – £110,150. These savings can be attributed to the pilot work and are just as important as prescribing savings.
Annualised prescribing cost savings have been calculated at £11,111 from the intervention log entries. These savings are attributed to the time spent working on the Medicines Optimisation workplan.
These are great results to date.
Megan Blythe – Senior Clinical Pharmacist